Calgary, dadAnd the October 20 2022 / cnw / – Siksika Health Services (SHS) has partnered with Orbex® medical technologies (Orpyx) is in a pilot program to help prevent and reduce the occurrence and recurrence of diabetic foot ulcers (DFU) for Siksika members with type 2 diabetes (T2D). financing through Methods of cooperation in the field of indigenous healthpartnership with Boehringer Ingelheim (Canada) Ltd.And the BimadzweinSupported by GMAK Consulting. This 24-week trial program will assess the effectiveness of using a digital treatment solution, Orpyx SI® Flexible sensory insoles with remote patient monitoring (RPM) services, to prevent DFUs. The pilot will be available to 35 Siksika Nation members who are currently living with type 2 diabetes.
Dr. commented. Tyler WhiteCEO of Siksika Health Services. “It’s all about quality of life and improving health, which is what we ultimately strive for here. Therefore, I am proud to collaborate with medical innovators such as Orpyx and GMAK Consulting.”
Approximately 25% of people with diabetes will develop DFU in their lifetime1with 49% DFU recurrence in the first year and 68% recurrence within five years2. in Albertathere is one amputation every 22 hours caused by DFU.3 Diabetes is a particularly devastating disease for the indigenous population of Canada17.2% of the indigenous population in the reservations were diagnosed with diabetes compared to 10% of the non-indigenous population.4
Dr. stated Brian EverettCEO and President of Orpyx. “Our long-term goal is to support Siksika Health Services in building a sustainable and cost-effective path to remote patient monitoring in order to deliver high-quality healthcare to the Siksika Nation community.”
“Exciting about this multiple collaboration with Siksika First Health Services and Orpyx is their innovative approach to preventing foot ulcers due to T2D complications using Orpyx SI.® Flexible sensory insoles and remote patient monitoring of their community members”, in detail Alison DerBimaadzwin, Senior Project Adviser. “Many of our employees have lost limbs due to this chronic disease and we are excited to contribute to a project that includes amputation prevention. Our goal at PATHWAYS is to improve patient care and improve health outcomes by collaborating with the public and private sectors in development with the community as a driver of system change. We are proud to support this The community-driven pilot model to test grassroots solutions with potential national impact and begin to fill healthcare gaps for our people across Turtle Island.”
- Siksika Health Services (SHS) is a leader in providing high quality, comprehensive healthcare to its members, restoring a state of wellness by providing responsible and efficient services as recognized by Accreditation Canada since 2005. With a population of over 8000 people, cexica nation It is located one hour east Calgaryis considered one of the Canada The most advanced and technologically advanced First Nation communities, including being a leading community primary service provider.
- Orbex for Medical Technology (Orbex) is a digital therapy company with a comprehensive end-to-end solution for healthy life extension for people with diabetes. Orpyx SI is backed by a strong intellectual property portfolio with over 90 patents® Clinically proven that the Sensory Sole System, with remote patient monitoring, helps detect and prevent complications from diabetic peripheral neuropathy. The insoles contain built-in sensors with extensive capabilities to measure physiological and physical parameters in the real world, which are then available to patients and their providers resulting in continuous personalized and preventive care.
- Bimadzwein It means “life” or “the good way” in Anishinaabe. An Indigenous-led advisory and policy team focused on enabling First Nations communities to successfully rebuild the nation by advancing healthy governance and economic development.
- Boehringer Ingelheim (Canada) Ltd. is a global, research-driven pharmaceutical company comprising many diverse cultures and societies.
- GMAK Consulting Transformative healthcare has supported and partnerships for a diverse population, including Indigenous health, for more than 20 years as a physician, senior leader, strategist and innovator. GMAK Consulting facilitated the introduction of SHS and Orpyx and will participate in the project from a clinical, cultural and healthcare perspective.
- Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment of diabetic foot ulcers. Lancet 2005; 366 (9498): 1725-35
- David J ArmstrongDPM, MD, PhD, Andrew JM BoltonBose, MD, MD, and Seco A. Boss, PhD, Diabetic foot ulcers and their recurrence. Ingle G-Med 2017; 376: 2367-2375
Source: Orpyx Medical Technologies Inc.
For more information: Contacts: Ryan Running Rabbit, Communications, Siksika Health Services, (403) 361 0584, [email protected]; Karen Smith, Marketing, Orpyx Medical Technologies, (210) 823-9604, [email protected]
#Siksika #Health #Services #Orpyx #GMAK #Consulting #collaborate #eliminate #foot #complications #type #diabetics #PATHWAYS #Indigenous #Health #Collaborations #Program